Equity
Balance – as of period end · $M
Q1 2025
1,042$M
All values (16)
| Period | Value ($M) | Status |
|---|---|---|
| Q2 2026 | 1,726 | reported |
| Q1 2026 | 1,494 | reported |
| Q4 2025 | 1,364 | reported |
| Q3 2025 | 1,272 | reported |
| Q2 2025 | 1,136 | reported |
| Q1 2025 | 1,042 | reported |
| Q4 2024 | 965 | reported |
| Q3 2024 | 890 | reported |
| Q2 2024 | 845 | reported |
| Q1 2024 | 809 | reported |
| Q4 2023 | −98 | reported |
| Q3 2023 | −117 | reported |
| Q2 2023 | −117 | reported |
| Q1 2023 | −100 | reported |
| Q4 2022 | −85 | reported |
| Q1 2022 – Q3 2022 | – | missing (3 periods): No verified SEC value extracted, although the company reports this metric in other periods. |
| Q4 2021 | None | error |
| Q1 2016 – Q3 2021 | – | missing (23 periods): Grund wie bei Q1 2022 – Q3 2022. |
Show reported periods only · CSV with all sources · Technical ID: equity
More metrics for Astera Labs
Income statement
Balance sheet
Revenue by segment/product/region
Sources & calculation
- Value
- $1.0B
- Period
- Q1 2025, ended Mar 31, 2025 · as of Mar 31, 2025 (balance as of date, not a sum)
- Source
- 10-Q, filed May 7, 2025 · 0001736297-25-000031
- Location
- us-gaap:StockholdersEquity
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | $1.0B | May 7, 2025 | 10-Q 0001736297-25-000031 | reported · confidence 1. · current |